NCT04784988View on ClinicalTrials.gov

Intensive Replacement Treatment in Haemophilia Patients With Synovitis

PHASE4CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 1, 2022

Primary Completion Date

March 1, 2023

Study Completion Date

March 1, 2024

Conditions
Hemophilia A
Interventions
DRUG

EHL-FVIII

prophylaxis with EHL-FVIII targeting a 12% FVIII through level based on PK assessment with WAPPS-Hemo

DRUG

FVIII concentrate

standard prophylaxis with FVIII concentrate according to current guidelines

Trial Locations (1)

80131

Matteo Di Minno, Napoli

All Listed Sponsors
lead

Federico II University

OTHER